Tocilizumab improved clinical symptoms of a patient with systemic tophaceous gout who had symmetric polyarthritis and fever: An alternative treatment by blockade of interleukin-6 signaling

Chronic tophaceous gout is the end stage of gout. We employed a blockade of interleukin-6 signaling therapy by tocilizumab instead of anakinra, an interleukin-1 receptor antagonist, for a 61-year-old Japanese woman diagnosed with tophaceous gout. Laboratory data showed that serum interleukin-6 conce...

Descripción completa

Detalles Bibliográficos
Autores principales: Mokuda, Sho, Kanno, Masamoto, Takasugi, Kiyoshi, Okumura, Chikara, Ito, Yuki, Masumoto, Junya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857353/
https://www.ncbi.nlm.nih.gov/pubmed/27489636
http://dx.doi.org/10.1177/2050313X13519774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857353/
https://www.ncbi.nlm.nih.gov/pubmed/27489636
http://dx.doi.org/10.1177/2050313X13519774

Ejemplares similares